共 50 条
A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
被引:0
|作者:
Chukwueke, Ugonma
[1
]
Wright, Isobel
[1
]
Muzikansky, Alona
[2
]
Russ, Alyssa
[1
]
Fontana, Brittney
[1
]
Kats, Vanessa
[1
]
O'Donnell, Colin
[3
]
Scalfani, Renee
[1
]
Acevedo-Naranjo, Brenda
[1
]
Lee, Eudocia
[1
]
Castro, Luis Nicolas Gonzalez
[4
]
McFaline-Figueroa, Jose Ricardo
[4
]
Aquilanti, Elisa
[1
]
Youssef, Gilbert
[4
]
Beroukhim, Rameen
[4
]
Forst, Deborah
[5
]
Reardon, David
Wen, Patrick
[6
]
Batchelor, Tracy
[1
]
Torres, Alexandra
[1
]
Stefanik, Jennifer
[1
]
Fisher, Jennifer
[1
]
Meredith, David
[7
]
Murakami, Mark
[1
]
Garcia, Yuri
[1
]
Shipp, Margaret
[1
]
Nayak, Lakshmi
[1
]
机构:
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Dept Neurol,Div Neurooncol, Boston, MA USA
[6] Brigham & Womens Canc Ctr, Dana Farber, Boston, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
来源:
关键词:
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
CTIM-39
引用
收藏
页数:2
相关论文